# OnCo record porfimer-sodium (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/porfimer-sodium/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "porfimer-sodium" ;
  schema:name "Porfimer sodium"@en ;
  schema:description "Porfimer sodium is the drug half of photodynamic therapy: injected, it gathers in tumours, and a laser passed through an endoscope two days later activates it to burn away oesophageal and lung tumours that block the airway or gullet."@en ;
  schema:url <https://onco.cc/drugs/porfimer-sodium/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Porfimer_sodium> ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020451>, <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=porfimer>, <https://en.wikipedia.org/wiki/Porfimer_sodium> ;
  onco:status "established" ;
  onco:tag "gap-fill", "chembl-universe" ;
  onco:modality "Photosensitiser for photodynamic therapy, intravenous then laser light" ;
  schema:alternateName "Photofrin" ;
  onco:approval "US 1995: Palliation of completely or partially obstructing oesophageal cancer; later endobronchial NSCLC and Barrett's high-grade dysplasia" ;
  onco:cancers <https://onco.cc/cancers/esophageal/>, <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:companies <https://onco.cc/companies/pinnacle-biologics/> ;
  onco:trials <https://onco.cc/trials/nct00003788/>, <https://onco.cc/trials/nct00513539/>, <https://onco.cc/trials/nct02628665/> .